Patrick Campbell

Chief Medical Officer of Applied Therapeutics discusses a study presented at ADA 2020 examining use of an aldose reductase inhibitor for diabetic complications.

Results of the EXPERT study could help guide clinical decision making for GLP-1 RA-experienced patients.

Discussing a look at the current life expectancy of patients with T2DM with an assistant professor from the University of Florida’s College of Pharmacy.

Discussing the results of a phase 2 study from Diasome examining use of HDV-insulin in type 1 diabetics.

Silvio Inzucchi, MD, discusses an EMPA-REG OUTCOME analysis assessing the impact of empagliflozin in patients who experience an initial dip in eGFR.

Bruce Bode, MD, discusses the results of a proof-of-concept study examining insulin and glucagon coadministration to prevent hypoglycemia and hyperglycemia in type 1 diabetics.

Deepak Bhatt, MD, MPH, discusses the results of the latest REDUCE-IT analysis, titled REDUCE-IT DIABETES, presented at ADA 2020.

Kieran Docherty, MBChB, discusses the results of a DAPA-HF analysis he presented at ADA 2020.

Discussing the effect of canagliflozin in patients with diabetes and chronic kidney disease with Meg Jardine, MBBS, PhD.

A recent analysis is examining potential factors associated with adverse gastrointestinal events in patients using semaglutide and whether it mitigates benefit.

Discussing data from ADA 2020 with a professor of medicine at University of Texas Southwestern.

A new randomized, crossover trial is examining the impact of eating dinner too late in the evening.

Increased physical activity could reduce the risk of developing age-related cataracts by up to 10%.

An NIH-funded analysis of the Jackson Heart Study is diving deeper into the impact of smoking on African Americans.

A new study from the University of Arizona is shedding light on the psychological impact of Tai Chi in patients with cardiovascular disease.

Analysis of the Framingham Heart Study indicates the rate of ICH in older patients has been on the rise and suggests anticoagulant use could have contributed to this increase.

A new analysis examines impact of treatment adherence in more than 1.2 million patients.

Study investigators have completed what they call the most comprehensive characterization of elementary school-age concussions to date.

A new observational analysis from the University of Mississippi Medical Center is disputing the notion marijuana use increases stroke risk.

A new retrospective chart review is examining effectiveness of nitrous oxide during labor and potential predictors to conversion to other therapies.

New research from Nutrition Live Online 2020 is diving into the impact of high and low quality carbohydrates on diabetes risk.

An analysis of claims data from 2018 finds spending on diabetes-related supplies is greater than that of insulin, which accounts for nearly 20% of out-of-pocket healthcare spending.

Despite normally being associated with end of life care, new research suggest palliative care could benefit heart failure patients.

The expanded indication is the first regulatory approval for aspirin plus ticagrelor dual antiplatelet therapy in those with a high risk, but no history of heart attack or stroke.

A new systematic review and meta-analysis is shedding light on the potential impact of inadequate health literacy on mortality and hospitalizations in heart failure patients.

A Q&A with Anne Fung, MD, Global Development Lead for the Port Delivery System with ranibizumab at Genentech.

A new study from the University of Rochester indicates early intervention could help preserve or even restore visual abilities in stroke patients.

Discussing the results of a recent analysis that estimated the impact of comprehensive therapy with SGLT2 inhibitors, ARNIs, and MRAs in patients with HFrEF.

The latest scientific statement from the American Heart Association examines disparities in risk factors, social determinants of health, and management approaches for these patients.

Discussing the impact of COVID-19 on patients with neurologic conditions and how the rapid advent of telehealth has impacted interdisciplinary teams.